Avastin for cancer treatment gains FDA approval

August 17, 2014 4:47 PM

23 0

New drug approved for cervical cancer in combination with chemotherapy for longer survival period.

Genentech’s bevacizumab, referred to as Avastin on the market, has gained approval for use in combination chemotherapy for late-stage cervical cancer. The U.S. Food and Drug Administration detailed that the approval allows for the treatment of recurrent, persistent or metastatic cervical cancer with...

Read more

To category page